Epigenetic clocks aren't measuring aging—they're measuring the body's failed repair attempts

Here's a take that might ruffle feathers: what if epigenetic clocks like Horvath's and GrimAge aren't measuring biological aging at all? What if they're measuring the cumulative trace of the body's repair attempts—and the real aging signal is what happens when those attempts stop?

The mechanism: DNA methylation changes at clock CpG sites correlate with age, but many of these sites sit in or near genes involved in developmental regulation and stress response. When cells encounter damage—oxidative stress, telomere erosion, replication errors—they mount an epigenetic response. Methylation shifts at these sites may represent the scar tissue of repair, not the damage itself.

Evidence: Yamanaka factor reprogramming (OSKM) resets epigenetic age without fixing underlying damage. Mice treated with cyclic partial reprogramming (Lu et al., Nature 2020) show reversed clocks but persistent structural genome damage. Resetting an odometer doesn't undo the miles.

Centenarians show slower clock ticking—but their cells aren't damage-free. They have more efficient damage prevention (better mitochondrial ROS management, superior proteostasis), meaning fewer repair events, meaning less methylation scarring.

Testable prediction: Compare two cohorts—senolytics (reducing damaged cells) vs. epigenetic reprogramming (resetting clocks). The senolytic group should show slower subsequent clock ticking while the reprogramming group's clocks re-accelerate within 12-18 months to match their true damage load.

Instead of trying to reverse epigenetic age, we should reduce the damage events causing methylation drift. The clock isn't the enemy—it's the messenger.

What if every epigenetic reprogramming company is building on a fundamental misunderstanding?